Private equity firm Mansa Capital Management has secured additional capital commitments worth USD 15 million for its inaugural healthcare fund. The latest proceeds bring to around USD 50 million the total funds raised for the fund. Based in Boston, Mansa Capital looks for opportunities in the USD 2.5 trillion healthcare sector. Before introducing its new healthcare fund, the firm helped management teams increase revenues and come up with new products with exceptional value using its expertise in economics and healthcare policy.
Mansa Capital Managing Partners and Chief Investment Officer Ruben J. King-Shaw Jr said in a statement, "Raised from state pensions through emerging manager initiatives as well as high net worth individuals and family offices, participants in this latest round represent a broad and strong interest in the U.S. healthcare market among domestic, Caribbean and Latin American investors."
The investments of Mansa Capital range from USD 5 million to USD 10 million. Florida-based Long Term Care Management Company Independent Living Systems and Texas-based Wellness Company E4 Health Inc currently make up the fund's portfolio.
Mansa also puts its focus in firms that will enable it to meet the growing demand from Hispanic and Urban Populations. Mansa Partner & COO Jason Torres said in a statement, "We are particularly interested in companies catering to the unique healthcare needs of Hispanic and Urban Populations. It's our assertion that healthcare IT, which can facilitate customized and culturally-sensitive communications with minorities will improve education and outcomes once these largely uninsured groups are enrolled."
Mansa collaborates closely with their portfolio firms to be able to guide their development. It prides itself in having a team composed of industry veterans who have widespread knowledge about the intersection of clinical research, healthcare policy, demographic trends and tech development. This allows them to be able to identify and find solutions to problems as they come up.
Join the Conversation